Fluorescence polarization serology for veterinary brucellosis: anti-O-polysaccharide antibody biology, assay comparability, and decision-rule validation
Fluorescence polarization assays (FPAs) rapidly detect antibodies to the O-polysaccharide (OPS) of smooth Brucella lipopolysaccharide for veterinary brucellosis surveillance. Interpretation depends on both antibody biology and the measurement procedure. This focused narrative review links the biological target and operational measurand to the reported result, assay classification, and diagnostic interpretation. It draws on antibody and tracer research, veterinary validation studies, and a human multistage-screening example to examine assay comparison and decision-rule validation. OPS-FPA measures the host immunological response, whereas PCR detects Brucella DNA. Smooth vaccination and cross-reactive carbohydrate antigens limit the infection specificity of OPS reactivity. Camel evidence illustrates model-dependent accuracy estimates, and experimental elk findings show that antibody responses can decline despite persistent infection. The proposed risk-based framework matches validation evidence to the change assessed. Documented minor changes warrant focused verification and/or paired comparability studies proportionate to risk; changes in result definition or scale require justified bridging and decision-rule reassessment; and changes in biological target, host, specimen matrix, or intended use require diagnostic revalidation in the new setting. Exact unit conversion alone does not create a new assay. Priorities are decision-boundary specimens, well-characterized reference panels, uncertainty assessment, and independent evaluation of the complete serological–molecular pathway. Selected-subgroup accuracy and assay agreement alone cannot establish the performance of a deployed diagnostic strategy.
Authors
- Luyu Mao
- Shuya Yang
- Jinlong Ma
- Yongli Guo
- Yuncai Cui
- Mingchun Gao
Institutions
- Harbin Medical University (CN)
- Northeast Agricultural University (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fmicb.2026.2029235
- Primary Topic
- Brucella: diagnosis, epidemiology, treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00